Artigo de periodico

Longer-term oral antiplatelet use in stable post-myocardial infarction patients: Insights from the long Term rIsk, clinical manaGement and healthcare Resource utilization of stable coronary artery dISease (TIGRIS) observational study (2017)

• Authors:
  • Goodman, Shaun G.
  • Nicolau, Jose C.
  • Requena, Gema
  • Maguire, Andrew
  • Blankenberg, Stefan
  • Chen, Ji Yan
  • Granger, Christopher B.
  • Grieve, Richard
  • Pocock, Stuart J.
  • Simon, Tabassome
  • Yasuda, Satoshi
  • Vega, Ana Maria
  • Brieger, David
• Autor USP: NICOLAU, JOSÉ CARLOS - FM
• Unidade: FM
• DOI: 10.1016/j.ijcard.2017.02.062
• Subjects: INFARTO DO MIOCÁRDIO; DOENÇAS CARDIOVASCULARES; FÁRMACOS (SISTEMA CARDIOVASCULAR)
• Language: Inglês
• Imprenta:
  • Publisher place: Amsterdam
  • Date published: 2017
• Source:
  • Título do periódico: International Journal of Cardiology
  • ISSN: 0167-5273
  • Volume/Número/Paginação/Ano: v. 236, p. 54-60, 2017

Informações sobre o DOI: 10.1016/j.ijcard.2017.02.062 (Fonte: oaDOI API)
• Este periódico é de assinatura
• Este artigo é de acesso aberto
• URL de acesso aberto
• Cor do Acesso Aberto: bronze
• Licença: publisher-specific-oa

---

How to cite

A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

• ABNT

  GOODMAN, Shaun G. et al. Longer-term oral antiplatelet use in stable post-myocardial infarction patients: Insights from the long Term rIsk, clinical manaGement and healthcare Resource utilization of stable coronary artery dISease (TIGRIS) observational study. International Journal of Cardiology, v. 236, p. 54-60, 2017Tradução . . Disponível em: https://doi.org/10.1016/j.ijcard.2017.02.062. Acesso em: 12 jun. 2024.

• APA

  Goodman, S. G., Nicolau, J. C., Requena, G., Maguire, A., Blankenberg, S., Chen, J. Y., et al. (2017). Longer-term oral antiplatelet use in stable post-myocardial infarction patients: Insights from the long Term rIsk, clinical manaGement and healthcare Resource utilization of stable coronary artery dISease (TIGRIS) observational study. International Journal of Cardiology, 236, 54-60. doi:10.1016/j.ijcard.2017.02.062

• NLM

  Goodman SG, Nicolau JC, Requena G, Maguire A, Blankenberg S, Chen JY, Granger CB, Grieve R, Pocock SJ, Simon T, Yasuda S, Vega AM, Brieger D. Longer-term oral antiplatelet use in stable post-myocardial infarction patients: Insights from the long Term rIsk, clinical manaGement and healthcare Resource utilization of stable coronary artery dISease (TIGRIS) observational study [Internet]. International Journal of Cardiology. 2017 ; 236 54-60.[citado 2024 jun. 12 ] Available from: https://doi.org/10.1016/j.ijcard.2017.02.062

• Vancouver

  Goodman SG, Nicolau JC, Requena G, Maguire A, Blankenberg S, Chen JY, Granger CB, Grieve R, Pocock SJ, Simon T, Yasuda S, Vega AM, Brieger D. Longer-term oral antiplatelet use in stable post-myocardial infarction patients: Insights from the long Term rIsk, clinical manaGement and healthcare Resource utilization of stable coronary artery dISease (TIGRIS) observational study [Internet]. International Journal of Cardiology. 2017 ; 236 54-60.[citado 2024 jun. 12 ] Available from: https://doi.org/10.1016/j.ijcard.2017.02.062

Últimas obras dos mesmos autores vinculados com a USP cadastradas na BDPI:

• Ticagrelor versus clopidogrel in patients with STEMI treated with fibrinolysis TREAT trial
• Ticagrelor vs Clopidogrel After Fibrinolytic Therapy in Patients With ST-Elevation Myocardial Infarction: A Randomized Clinical Trial (vol 3, pg 391, 2018)
• Effects of Dapagliflozin on Symptoms, Function, and Quality of Life in Patients With Heart Failure and Reduced Ejection Fraction Results From the DAPA-HF Trial
• Efficacy and Safety of Dapagliflozin in Heart Failure With Reduced Ejection Fraction According to Age Insights From DAPA-HF
• Effect of alirocumab on mortality after acute coronary syndromes an analysis of the ODYSSEY OUTCOMES randomized clinical trial
• Predicting risk of cardiovascular events 1 to 3 years post-myocardial infarction using a global registry
• Long-term ticagrelor for secondary prevention in patients with prior myocardial infarction and no history of coronary stenting: insights from PEGASUS-TIMI 54
• Two-year outcomes among stable high-risk patients following acute MI. Insights from a global registry in 25 countries
• Anti-Thrombotic Therapy to Ameliorate Complications of COVID-19 (ATTACC): Study design and methodology for an international, adaptive Bayesian randomized controlled trial
• Rationale and design of the long-Term rIsk, clinical manaGement, and healthcare Resource utilization of stable coronary artery dISease in post-myocardial infarction patients (TIGRIS) study